tiprankstipranks
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE

Sorrento Therapeutics (SRNE) Technical Analysis

5,283 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Sorrento Therapeutics’s (SRNE) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Sorrento Therapeutics is a Sell.
Sorrento Therapeutics’s (SRNE) 20-Day exponential moving average is 0.01, while Sorrento Therapeutics’s (SRNE) share price is <$0.1, making it a Sell.
Sorrento Therapeutics’s (SRNE) 50-Day exponential moving average is 0.02, while Sorrento Therapeutics’s (SRNE) share price is <$0.1, making it a Sell.

Sorrento Therapeutics (SRNE) Pivot Points

Jul 07, 2024, 05:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
>-0.01
<0.01
<0.01
0.01
0.02
0.02
0.03
Fibonacci
<0.01
<0.01
<0.01
0.01
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sorrento Therapeutics (SRNE) Moving Averages

Jul 07, 2024, 05:25 AM
Period
Simple
Exponential
MA5
<0.01Buy
0.01Sell
MA10
0.01Sell
0.01Sell
MA20
0.01Sell
0.01Sell
MA50
0.01Sell
0.02Sell
MA100
0.02Sell
0.03Sell
MA200
0.06Sell
0.08Sell
Sorrento Therapeutics’s (SRNE) 10-Day exponential moving average is 0.01, while Sorrento Therapeutics’s (SRNE) share price is <$0.1, making it a Sell.
Sorrento Therapeutics’s (SRNE) 100-Day exponential moving average is 0.03, while Sorrento Therapeutics’s (SRNE) share price is <$0.1, making it a Sell.
Sorrento Therapeutics’s (SRNE) stock price is <$0.1 and Sorrento Therapeutics’s (SRNE) 50-day simple moving average is 0.01, creating a Sell signal.
Sorrento Therapeutics’s (SRNE) stock price is <$0.1 and Sorrento Therapeutics’s (SRNE) 100-day simple moving average is 0.02, creating a Sell signal.
Sorrento Therapeutics’s (SRNE) stock price is <$0.1 and Sorrento Therapeutics’s (SRNE) 200-day simple moving average is 0.06, creating a Sell signal.

Sorrento Therapeutics (SRNE) Technical Indicators

Jul 07, 2024, 05:25 AM
Name
Value
Implied Action
RSI (14)
42.24
Neutral
STOCH (9,6)
38.61
Neutral
STOCHRSI (14)
50.26
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
13.82
Buy
Williams %R
-44.44
Buy
CCI (14)
-145.12
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
27.44
Sell
ROC
0.00
-
Sorrento Therapeutics’s (SRNE) Relative Strength Index (RSI) is 42.24, creating a Neutral signal.
Sorrento Therapeutics’s (SRNE) Trend Strength Indicator (ADX) is 13.82, creating a Buy signal.
Sorrento Therapeutics’s (SRNE) Commodity Channel Index (CCI) is -145.12, creating a Buy signal.

FAQ

Is SRNE a Buy, Hold, or Sell?
Based on SRNE’s technical indicators, SRNE is a Sell.
    What is SRNE’s RSI (14)?
    SRNE’s RSI (14) is 42.24, which suggests SRNE is a Neutral.
      What is SRNE’s MACD?
      SRNE’s MACD is >-0.01, which suggests SRNE is a Sell.
        What is SRNE’s 5-day moving average?
        SRNE’s 5-day moving average is <0.01, which suggests SRNE is a Buy.
          What is SRNE’s 20-day moving average?
          SRNE 20-day moving average is 0.01, which suggests SRNE is a Sell.
            What is SRNE’s 50-day moving average?
            SRNE’s 50-day moving average is 0.01, which suggests SRNE is a Sell.
              What is SRNE’s 200-day moving average?
              SRNE’s 200-day moving average is 0.06, which suggests SRNE is a Sell.
                What is SRNE’s Williams % R (14)?
                SRNE’s Williams % R (14) is -44.44, which suggests SRNE is a Buy.
                  What is SRNE’s CCI (14)?
                  SRNE’s CCI (14) is -145.12, which suggests SRNE is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis